OS Therapies Employee Directory
Biotechnology ResearchNew York, United States11-50 Employees
OS Therapies is a clinical-stage biotechnology research company focused on therapies for osteosarcoma, breast cancer, and other solid tumors. Its two platform approaches aim to prevent metastasis and to debulk tumors, with OST-HER2 advancing in a Phase IIb/III-like development and OST-tADC pursuing a novel pre-clinical drug conjugate strategy that activates in the acidic cancer environment. The company operates from New York, NY, and maintains a relatively small team dedicated to developing targeted cancer treatments. As part of its work, OS Therapies engages in collaborations and participates in industry events to share clinical data and explore commercialization pathways. A recent development includes the appointment of a chief medical advisor, reflecting ongoing scientific leadership and clinical oversight.